Research Study
Vector-borne dPCR
The study will test the hypothesis that people with a Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Post-Treatment Lyme Disease Syndrome, or Ehler’s Danlos Syndrome (EDS) diagnosis may harbor tick-borne or vector-borne pathogens in blood whose activity could be contributing to chronic symptoms. These tick-borne or vector-borne pathogens include Borrelia (the agent of Lyme Disease), Babesia, and Bartonella.
Is this a virtual opportunity?
No, this is not a virtual opportunity.
What are the location requirements?
You must be located in the USA.
Will there be in-person visits? If so, how many?
Yes, there will be 1 in-person visit.
Where is the study located?
5 East 98th Street, New York, New York, USA.
What is the length of participation?
The length of participation is 8 weeks.
What health qualifications are there to participate?
Long COVID (required proof of COVID infection which caused Long COVID)
Post-Treatment Lyme Disease Syndrome (required proof of Lyme)
ME/CFS (pre-2020 or not related to COVID)
Ehlers-Danlos Syndrome
Healthy Control
What kinds of tasks are associated with participation?
There will be blood draws.